42 related articles for article (PubMed ID: 7652595)
1. [Effect of U-50, 488H administered centrally in rats on urination and activity of TH-IR neurons in PVH].
Di AK; Huang L
Sheng Li Xue Bao; 1995 Apr; 47(2):187-94. PubMed ID: 7652595
[TBL] [Abstract][Full Text] [Related]
2. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
[TBL] [Abstract][Full Text] [Related]
3. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
[TBL] [Abstract][Full Text] [Related]
5. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
6. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
[TBL] [Abstract][Full Text] [Related]
7. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats.
Bileviciute-Ljungar I; Spetea M
Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967
[TBL] [Abstract][Full Text] [Related]
8. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C.
Bian JS; Wang HX; Zhang WM; Wong TM
Br J Pharmacol; 1998 Jun; 124(3):600-6. PubMed ID: 9647487
[TBL] [Abstract][Full Text] [Related]
9. Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat.
Gu B; Fraser MO; Thor KB; Dolber PC
J Urol; 2004 Jan; 171(1):472-7. PubMed ID: 14665958
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
11. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
Bhargava HN; Kumar S
Brain Res; 1997 Feb; 749(2):347-50. PubMed ID: 9138737
[TBL] [Abstract][Full Text] [Related]
12. Cross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Milanés MV; Laorden ML
J Pharmacol Exp Ther; 1995 Feb; 272(2):658-62. PubMed ID: 7853179
[TBL] [Abstract][Full Text] [Related]
13. Role of the nitric oxide pathway in kappa-opioid-induced hypothermia in rats.
Benamar K; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Oct; 303(1):375-8. PubMed ID: 12235273
[TBL] [Abstract][Full Text] [Related]
14. Delayed uncoupling is related to cardioprotection induced by kappa-agonist U-50,488H in rat heart.
Chen BP; Mao HJ; Fan FY; Bruce IC; Xia Q
Scand Cardiovasc J; 2005 Dec; 39(6):375-82. PubMed ID: 16352491
[TBL] [Abstract][Full Text] [Related]
15. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Laorden ML; Milanés MV
J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis.
Bileviciute-Ljungar I; Saxne T; Spetea M
Rheumatology (Oxford); 2006 Mar; 45(3):295-302. PubMed ID: 16249243
[TBL] [Abstract][Full Text] [Related]
17. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
[TBL] [Abstract][Full Text] [Related]
18. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.
Bhargava HN
Gen Pharmacol; 1995 Sep; 26(5):1055-60. PubMed ID: 7557250
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze.
Privette TH; Terrian DM
Psychopharmacology (Berl); 1995 Apr; 118(4):444-50. PubMed ID: 7568631
[TBL] [Abstract][Full Text] [Related]
20. Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats.
Cabral AM; Varner KJ; Kapusta DR
J Pharmacol Exp Ther; 1997 Aug; 282(2):609-16. PubMed ID: 9262322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
